Status:
COMPLETED
Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Brain Concussion
Post-Concussion Syndrome
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study will evaluate the practicality (i.e. acceptability to stakeholders; outcome battery feasibility; recruitment, retention, and adherence rates) and the preliminary effect of a cognitive strat...
Detailed Description
Up to 90% of known traumatic brain injuries are classified as mild, with many more injuries likely going undetected. While each of these individuals experiences somatic, cognitive, and/or affective sy...
Eligibility Criteria
Inclusion
- Participants will be included if have a physician diagnosis of mTBI or if they meet the following criteria for mild traumatic brain injury established by the American Congress of rehabilitation Medicine including a traumatically induced physiological disruption of brain function, as manifested by at least one of the following: any loss of consciousness, any loss of memory for events immediately before or after the accident, any alteration in mental state at the time of the accident (e.g., feeling dazed, disoriented, or confused), and focal neurologic deficit(s) that may or may not be transient; severity of injury should not exceed a loss of consciousness \>30 minutes, at 30 minutes post-injury a Glasgow Coma Scale score more severe than 13-15, or post-traumatic amnesia \>24 hours.
- One or more post-concussive symptoms persisting for greater than 4 weeks that is inhibiting performance of one or more daily activities
- Age 18-60 years
Exclusion
- Any additional severe neurologic or psychiatric conditions
- severe depressive symptoms per a score of \>21 on the Patient Health Questionnaire (PHQ-9)
- inability to read, write, and speak English fluently
- lack of transportation to intervention sessions
Key Trial Info
Start Date :
October 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04681742
Start Date
October 15 2020
End Date
December 31 2022
Last Update
March 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Missouri-Columbia
Columbia, Missouri, United States, 65212